The market rallied on the seventh day after six days of losses but we still have  a few hours to go. The Dow is up 0.96% and the NAZ is up 0.64%.Life Science stocks are strong overall with mid-caps up 0.75%. Diagnostics and tools are the strongest sector and within the Raygent Portfolio all Tools and Dx are up except CSII and GPRO. Keep an eye on diagnostics as the AACC Annual Meeting is coming up on JY 24 in Atlanta.

Big winners today are Abaxis (ABAX), Alere (ALR), Exact Sciences(EXAS) and Quidel (QDEL).

The only bad day in biotech was favorite Vertex (VRTX $48.25) down 9% after reporting Phase II study data on its VX-770/VX-809 combination drug for cystic fibrosis.The data showed some improved function but some analysts were disappointed but further studies are being done so there is still potential for approval longer term.On May 23  Vertex received FDA approval for its HCV drug Incivek and the stock peaked.

Chart forVertex Pharmaceuticals Incorporated (VRTX)

%d bloggers like this: